Figures & data
Table 1 Patient Characteristics
Table 2 Number of Patients Receiving the Reference Infliximab or Its Biosimilar for Target Disease Diagnosis (Whole, with or without Subsidy for Intractable Disease) Throughout the Study Period from 2014 to 2018
Figure 1 Patient flow chart. *Target diseases: RA (ICD10 Code: M05, M06), UC (ICD10 Code: K51), CD (ICD10 Code: K50), and Ps (ICD10 Code: L40).
![Figure 1 Patient flow chart. *Target diseases: RA (ICD10 Code: M05, M06), UC (ICD10 Code: K51), CD (ICD10 Code: K50), and Ps (ICD10 Code: L40).](/cms/asset/416382be-ee5a-4765-a072-3c62449ab33d/dceo_a_12162321_f0001_b.jpg)